Table 5.
SAMPLE | Total number of reads | Mean Target Coverage | % target bases covered at least 10X | % target bases covered at least 20X | % target bases covered at least 50X | % target bases covered at least 100X |
---|---|---|---|---|---|---|
357muscle | 55,062,491 | 35.5 | 88.9% | 66.7% | 19.6% | 3.3% |
368muscle | 68,408,757 | 43.6 | 92.1% | 75.1% | 28.2% | 5.8% |
373muscle | 125,208,792 | 69.7 | 96.1% | 88.5% | 54.2% | 18.3% |
358muscle | 249,603,786 | 128.7 | 98.0% | 95.4% | 80.1% | 49.2% |
358N1 | 52,236,649 | 33.8 | 88.1% | 64.8% | 18.1% | 3.0% |
357N5 | 59,870,967 | 37.5 | 90.0% | 69.5% | 22.3% | 4.1% |
368N8 | 69,492,339 | 43.2 | 91.9% | 75.0% | 28.6% | 6.1% |
373N4 | 92,890,008 | 55.4 | 94.0% | 82.4% | 42.4% | 12.2% |
368N2 | 126,289,004 | 63.6 | 95.8% | 87.2% | 50.1% | 15.5% |
357N1 | 140,082,301 | 77.6 | 96.2% | 89.4% | 59.0% | 23.8% |
358N3 | 144,107,456 | 78.4 | 96.5% | 90.2% | 61.2% | 25.2% |
373N3 | 141,719,445 | 84.8 | 96.7% | 91.0% | 64.2% | 28.4% |
357N4 | 172,106,294 | 91.2 | 97.2% | 92.4% | 67.3% | 31.1% |
368N4 | 207,370,862 | 110.2 | 97.9% | 94.8% | 76.5% | 42.3% |
358N2 | 209,306,186 | 113.7 | 97.8% | 94.5% | 76.3% | 43.0% |
373N1 | 235,568,319 | 123.9 | 97.9% | 95.0% | 79.0% | 47.9% |
Statistics about whole-exome sequencing are given. These include the total number of reads, the mean target coverage and the percent of target bases covered at least at 10X, 20X, 50X and 100X for each tumor and muscle tissue sample.